Dr Beatrice Seddon, Consultant Clinical Oncologist
Dr Beatrice Seddon
Consultant Clinical Oncologist
Dr Beatrice Seddon MBBS MRCP FRCR PhD
Consultant Clinical Oncologist
Areas of expertise
- Soft tissue disorders
- Sarcoma
- Gastrointestinal stromal tumours
- Chemotherapy
- Radiotherapy
Recommendations for Dr Seddon
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
HCA UK at University College Hospital
Grafton Way Building, 1 Grafton Way, London, WC1E 6AG
-
LOC - Leaders in Oncology Care
95-97 Harley Street, London, W1G 6AF
About Dr Beatrice Seddon
GMC number: 3453405
Year qualified: 1990
Place of primary qualification: University of London
Dr Beatrice Seddon is a highly experienced consultant specialising in the treatment of bone and soft tissue sarcomas. With 20 years of dedicated service, she has made significant contributions to the field of oncology. Dr Seddon was a key member of the Sarcoma Unit at University College Hospital until 2022, where she treated patients using advanced chemotherapy and radiotherapy techniques, including proton beam therapy, which is available to private patients through Proton International London.
Dr Seddon received her specialised training in sarcoma treatment at the prestigious Royal Marsden and Middlesex Hospitals in London. Her expertise lies exclusively in the management of soft tissue and bone sarcomas, utilising both chemotherapy and radiotherapy to provide comprehensive care.
In addition to her clinical practice, Dr Seddon completed her PhD at the Institute of Cancer Research, focusing on the imaging of tumour hypoxia. She has a profound interest in clinical trials related to sarcoma and has served as principal and chief investigator for numerous national and international studies on sarcoma chemotherapy and radiotherapy. Her commitment to advancing sarcoma research is evident through her active involvement in the NCRN Sarcoma Clinical Studies Group, the NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad), and the EORTC Soft Tissue and Bone Sarcoma Group.
Dr Seddon is also a dedicated educator, regularly teaching and lecturing on the management of sarcomas. Her areas of expertise include the treatment of soft tissue sarcomas, bone sarcomas, gastrointestinal stromal sarcoma, and gynaecological sarcomas such as leiomyosarcoma, endometrial stromal sarcoma, and PEComa. She is proficient in administering chemotherapy and various forms of radiotherapy, including intensity modulated radiotherapy (IMRT) and proton beam therapy (PBT).
Dr Beatrice Seddon’s extensive experience, combined with her commitment to research and education, makes her a leading figure in the field of sarcoma treatment. She continues to provide exceptional care to her patients while contributing to the advancement of oncology through her research and teaching efforts.
Areas of expertise
- Soft tissue and bone sarcomas
- Gastrointesintal stromal tumours
- Gynaecological sarcomas
Professional memberships
Articles by Dr Beatrice Seddon
Title: whole genome sequencing of 1,111 sarcoma probands reveals pot-1 as a sarcoma predisposition gene presentation type: oral current category: basic science|genomics authors (first name, last name)
The hypoxia marker caix is prognostic in the uk phase iii vortex-biobank cohort: an important resource for translational research in soft tissue sarcoma
Cediranib in patients with alveolar soft-part sarcoma (casps): a double-blind, placebo-controlled, randomised, phase 2 trial
Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood
Po-0742: target delineation conformity in extremity sts within the uk phase ii multi-centre imris trial